Lípidos Sanguíneos y Riesgo Cardiovascular

de Miguel-Yanes, JM; Shrader, P; Pencina, MJ; Fox, CS; Manning, AK; Grant, RW; Dupuis, J; Florez, JC; D'Agostino, RB; Cupples, LA; Meigs, JB.

Genetic Risk Reclassification for Type 2 Diabetes by Age Below or Above 50 Years Using 40 Type 2 Diabetes Risk Single Nucleotide Polymorphisms

DIABETES CARE. 2011; 34(1): 121-125 Nº de citas: 144 [doi:10.2337/dc10-1265]

Conthe, P; Mata, M; Orozco, D; Pajuelo, F; Barreto, CS; Anaya, SF; Gomis, R.

Degree of control and delayed intensification of antihyperglycaemic treatment in type 2 diabetes mellitus patients in primary care in Spain

DIABETES RESEARCH AND CLINICAL PRACTICE. 2011; 91(1): 108-114 Nº de citas: 27 [doi:10.1016/j.diabres.2010.10.002]